New Study Shows Brainomix's Unique AI-Driven Software Gives Doctors Reliable Information to Treat Stroke Patients from Universally Available Imaging Systems

App Will Empower Breast Implant Patients by Providing a Digital Wallet with Their Implant Record and Serve as a Two-Way Doctor-Patient Communications Tool

In stark contrast to Democrats who seek to push all Americans into socialized medicine, an Executive Order signed on October 3 by President Donald Trump takes bold steps toward increasing the ability of American seniors to choose the medical care and insurance options best for them, instead of being trapped within increasingly insolvent government-run programs.

GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA), an immuno-oncology company focused on innovative treatments based on the Company's patent pending TriKE™ technology, announced today that Tim Schacker, M.D., Jeffrey S. Miller, M.D., and their colleagues at the University of Minnesota presented data during a poster session held at the 18th meeting of the Society for Natural Immunity in Luxembourg discussing their design of an HIV-TriKE™ containing an antigen binding fragment (Fab) from a broadly-neutralizing antibody targeting the HIV-Env protein.

Study met both co-primary endpoints with high statistical significance, demonstrating autograft sparing and durable wound closure at three months with StrataGraft

Merck KGaA, Darmstadt, Germany, a leading science and technology company, which operates its biopharmaceutical business as EMD Serono in the US and Canada, today announced that new data representing several key therapeutic agents from its diverse oncology pipeline will be presented at the 2019 European Society for Medical Oncology (ESMO) Congress, September 27–October 1, in Barcelona, Spain.

Precision Medical Products Streamlines Operations to Achieve 70 Percent Growth in Three Years with NetSuite

Canadian Breast Cancer Network and Self Care Catalysts announce strategic partnership, collaborating on expanding Breast Cancer literacy through a patient engagement, health tracking platform and real-world evidence research.

Dance Biopharm signs an agreement with DarioHealth to integrate Dance's gentle mist smart inhaler into DarioHealth's platform allowing for automated, real-time treatment data through a mobile application

A joint venture between Atropos and Atomwise will discover and develop anticancer agents using senescence assay and AI technologies

"Interoperability" – a fancy term for the ability to exchange medical data among health-care providers and institutions – is increasingly important in a technologically advancing age, with medicine becoming the realm of highly specialized diagnosticians and others who rely on applied technology for effective treatment.

Internationally recognized leaders to advise on innovations in pregnancy care for the 21st century

The United States is one of the most dangerous places in the developed world for a black woman giving birth and for black infants in their first year of life.

Harvard-trained, nationally renowned neuropsychiatrist develops Emerging Consciousness Program for children and adults

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Direct Relief and the National Association of Community Health Centers (NACHC) recently honored six community health centers in the U.S. with the "Innovations in Care" award in recognition of their success in low-resource areas identifying and assisting vulnerable people to better manage complex chronic diseases and improve their health.

According to the American Cancer Society, prostate cancer is the second most common cancer in American men, affecting more than 10 percent of the population.

Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, today announced dosing of the first patient in its Phase 3 EMERGE efficacy trial of STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine.

Collaborative program helps CROs deliver additional value to sponsors with best practices for Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions

Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study on Frontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health's Oncotype DX in patients with early-stage breast cancer.

Islam is the second-largest religion in the world and the fastest growing religion in the United States. Certified Registered Nurse Anesthetists (CRNAs) attending the American Association of Nurse Anesthetists (AANA) Annual Congress, August 9-13, 2019, in Chicago will have an opportunity to learn about this religion to help provide culturally competent care to Muslim patients.